End-of-day quote
Mexican S.E.
06:00:00 2024-05-30 pm EDT
|
5-day change
|
1st Jan Change
|
17.77
MXN
|
-4.51%
|
|
+6.53%
|
+25.49%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
18,932
|
19,061
|
21,614
|
16,849
|
13,161
|
16,795
|
-
|
-
|
Enterprise Value (EV)
1 |
24,043
|
23,381
|
26,264
|
21,719
|
17,681
|
20,241
|
19,624
|
19,683
|
P/E ratio
|
19.3
x
|
12.9
x
|
14.9
x
|
-
|
13.1
x
|
8.08
x
|
8.18
x
|
6.42
x
|
Yield
|
-
|
-
|
1.78%
|
-
|
1.38%
|
-
|
1.88%
|
-
|
Capitalization / Revenue
|
1.48
x
|
1.37
x
|
1.4
x
|
1
x
|
0.8
x
|
0.94
x
|
0.88
x
|
0.81
x
|
EV / Revenue
|
1.88
x
|
1.69
x
|
1.7
x
|
1.29
x
|
1.07
x
|
1.14
x
|
1.03
x
|
0.95
x
|
EV / EBITDA
|
9.35
x
|
7.97
x
|
8.18
x
|
6.26
x
|
5.12
x
|
5.2
x
|
4.63
x
|
4.17
x
|
EV / FCF
|
145
x
|
18
x
|
32.1
x
|
13.4
x
|
8.81
x
|
12.1
x
|
10.6
x
|
9.47
x
|
FCF Yield
|
0.69%
|
5.55%
|
3.11%
|
7.49%
|
11.4%
|
8.24%
|
9.46%
|
10.6%
|
Price to Book
|
2.38
x
|
2.05
x
|
1.96
x
|
-
|
1.44
x
|
1.44
x
|
1.24
x
|
-
|
Nbr of stocks (in thousands)
|
1,011,839
|
1,011,744
|
1,006,240
|
994,639
|
929,461
|
945,144
|
-
|
-
|
Reference price
2 |
18.71
|
18.84
|
21.48
|
16.94
|
14.16
|
17.77
|
17.77
|
17.77
|
Announcement Date
|
2/26/20
|
2/24/21
|
2/23/22
|
2/22/23
|
2/21/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
12,756
|
13,867
|
15,460
|
16,859
|
16,467
|
17,823
|
19,118
|
20,744
|
EBITDA
1 |
2,571
|
2,932
|
3,210
|
3,471
|
3,454
|
3,892
|
4,235
|
4,718
|
EBIT
1 |
2,435
|
2,777
|
3,063
|
3,263
|
3,224
|
3,503
|
3,963
|
4,464
|
Operating Margin
|
19.09%
|
20.03%
|
19.81%
|
19.35%
|
19.58%
|
19.66%
|
20.73%
|
21.52%
|
Earnings before Tax (EBT)
1 |
1,536
|
2,247
|
2,313
|
2,261
|
1,685
|
2,946
|
3,429
|
4,340
|
Net income
1 |
986.7
|
1,478
|
1,451
|
1,397
|
1,031
|
1,978
|
2,224
|
2,624
|
Net margin
|
7.74%
|
10.66%
|
9.39%
|
8.29%
|
6.26%
|
11.1%
|
11.63%
|
12.65%
|
EPS
2 |
0.9700
|
1.460
|
1.440
|
-
|
1.080
|
2.200
|
2.173
|
2.770
|
Free Cash Flow
1 |
165.3
|
1,297
|
817.3
|
1,626
|
2,008
|
1,667
|
1,856
|
2,078
|
FCF margin
|
1.3%
|
9.35%
|
5.29%
|
9.65%
|
12.19%
|
9.35%
|
9.71%
|
10.02%
|
FCF Conversion (EBITDA)
|
6.43%
|
44.23%
|
25.46%
|
46.86%
|
58.13%
|
42.83%
|
43.83%
|
44.04%
|
FCF Conversion (Net income)
|
16.75%
|
87.76%
|
56.33%
|
116.43%
|
194.81%
|
84.27%
|
83.48%
|
79.21%
|
Dividend per Share
2 |
-
|
-
|
0.3817
|
-
|
0.1961
|
-
|
0.3348
|
-
|
Announcement Date
|
2/26/20
|
2/24/21
|
2/23/22
|
2/22/23
|
2/21/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
|
4,063
|
4,015
|
4,324
|
4,349
|
4,171
|
4,178
|
4,370
|
4,393
|
3,525
|
4,197
|
-
|
-
|
-
|
4,637
|
4,900
|
EBITDA
|
889.9
|
826.6
|
892
|
912.4
|
839.9
|
867.3
|
920.1
|
933.7
|
732.3
|
935.6
|
-
|
-
|
-
|
996.4
|
1,059
|
EBIT
1 |
850.7
|
775.2
|
839.8
|
859.4
|
788.4
|
868.8
|
871.1
|
885.8
|
663.5
|
857.2
|
937.4
|
951.7
|
781.5
|
931
|
1,003
|
Operating Margin
|
20.94%
|
19.31%
|
19.42%
|
19.76%
|
18.9%
|
20.79%
|
19.93%
|
20.16%
|
18.82%
|
20.42%
|
-
|
-
|
-
|
20.08%
|
20.48%
|
Earnings before Tax (EBT)
1 |
604.5
|
498.8
|
613.6
|
614.2
|
534.8
|
491.3
|
574.9
|
548.3
|
70.58
|
517
|
745.8
|
769.7
|
599.5
|
760.6
|
818.7
|
Net income
1 |
359.2
|
339.2
|
404.7
|
399.3
|
253.6
|
358
|
417.4
|
370.7
|
-115.5
|
372.1
|
492.2
|
508
|
395.7
|
502
|
540.3
|
Net margin
|
8.84%
|
8.45%
|
9.36%
|
9.18%
|
6.08%
|
8.57%
|
9.55%
|
8.44%
|
-3.28%
|
8.87%
|
-
|
-
|
-
|
10.83%
|
11.03%
|
EPS
2 |
0.3600
|
0.3400
|
0.4000
|
0.4000
|
-
|
0.3700
|
0.4300
|
0.3900
|
-0.1200
|
0.3600
|
0.4698
|
0.4874
|
0.4838
|
0.4790
|
0.5156
|
Dividend per Share
2 |
0.3817
|
-
|
0.3817
|
-
|
-
|
-
|
0.1961
|
0.1961
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/23/22
|
4/27/22
|
7/27/22
|
10/26/22
|
2/22/23
|
4/26/23
|
7/26/23
|
10/25/23
|
2/21/24
|
4/24/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
5,112
|
4,320
|
4,650
|
4,870
|
4,520
|
3,446
|
2,828
|
2,888
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
1.988
x
|
1.473
x
|
1.449
x
|
1.403
x
|
1.309
x
|
0.8854
x
|
0.6678
x
|
0.6121
x
|
Free Cash Flow
1 |
165
|
1,297
|
817
|
1,626
|
2,008
|
1,667
|
1,857
|
2,078
|
ROE (net income / shareholders' equity)
|
12.6%
|
16.8%
|
14.1%
|
13.8%
|
10.6%
|
15.1%
|
15.7%
|
15.5%
|
ROA (Net income/ Total Assets)
|
5.28%
|
7.17%
|
6.51%
|
6.45%
|
4.88%
|
7.4%
|
9.15%
|
-
|
Assets
1 |
18,705
|
20,615
|
22,300
|
21,649
|
21,135
|
26,733
|
24,292
|
-
|
Book Value Per Share
2 |
7.870
|
9.200
|
11.00
|
-
|
9.830
|
12.40
|
14.30
|
-
|
Cash Flow per Share
|
0.9900
|
2.000
|
1.440
|
-
|
2.360
|
-
|
-
|
-
|
Capex
1 |
839
|
726
|
630
|
402
|
247
|
546
|
602
|
653
|
Capex / Sales
|
6.58%
|
5.23%
|
4.08%
|
2.38%
|
1.5%
|
3.06%
|
3.15%
|
3.15%
|
Announcement Date
|
2/26/20
|
2/24/21
|
2/23/22
|
2/22/23
|
2/21/24
|
-
|
-
|
-
|
Last Close Price
17.77
MXN Average target price
19.46
MXN Spread / Average Target +9.49% Consensus |
1st Jan change
|
Capi.
|
---|
| +25.49% | 1.03B | | +40.73% | 739B | | +32.83% | 598B | | -6.30% | 353B | | +15.15% | 318B | | +4.05% | 285B | | +15.00% | 240B | | +9.78% | 210B | | -5.52% | 206B | | +6.17% | 164B |
Other Pharmaceuticals
|